Anagenics Limited (ASX:AN1) Updates 2Q25 Activity Report
Financial Performance
Anagenics Limited achieved a net operating cash flow outflow of $0.3 million in 2Q25, a significant improvement from a $0.9 million outflow in the previous quarter.
Cost Reductions
The company implemented major cost-saving measures, reducing advertising and marketing expenses by 45% to $124k, staff and director costs by 42% to $409k, and admin and corporate costs by 66% to $156k.
Payments to Related Parties
Anagenics paid a total of $65k to related parties and their associates in 2Q25, including wages and fees paid to former directors and their associates, compared to $116k in Q1 FY2025.
Voluntary Suspension
The company continues efforts to reinstate its securities to quotation, expecting completion by the end of February 2025.
Motley Fool contributor Kiarra Jackson has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
This article was generated using GPT-4o mini, a Large Language Model (LLM), to generate summaries of investing news. While AI is generating the content, we know better than to blindly trust our future robot overlords, and every article is edited and fact-checked by an editor holding the appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content of everything published by The Capital Club.